We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JRVR icon
4876
James River Group Holdings
JRVR
$193M
$5K ﹤0.01%
238
-3,034
-93% -$69.6K
CPTL
4877
Global X Funds Global X Morningstar Capital Allocation Leaders ETF
CPTL
$120M
$5K ﹤0.01%
+186
New +$5.16K
LABU icon
4878
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
$5K ﹤0.01%
36
-3,023
-99% -$422K
TULP
4879
Bloomia Holdings
TULP
$5K ﹤0.01%
656
-846
-56% -$6.09K
LNZA icon
4880
LanzaTech
LNZA
$70.3M
$5K ﹤0.01%
5
-2
-29% -$1.97K
MEGL icon
4881
Magic Empire Global Ltd
MEGL
$6.23M
$5K ﹤0.01%
924
+867
+1,521% +$8.23K
MGLD icon
4882
Marygold Companies
MGLD
$46.1M
$5K ﹤0.01%
3,450
-2,509
-42% -$3.25K
MIST icon
4883
Milestone Pharmaceuticals
MIST
$137M
$5K ﹤0.01%
+1,247
New +$6.56K
MODD icon
4884
Modular Medical
MODD
$13.5M
$5K ﹤0.01%
+91
New +$8.19K
MOG.B icon
4885
Moog Inc Class B
MOG.B
$5K ﹤0.01%
62
-1
-2% -$85
MTRN icon
4886
Materion
MTRN
$5.9B
$5K ﹤0.01%
56
-11,501
-100% -$939K
NMTC icon
4887
NeuroOne Medical Technologies
NMTC
$16.9M
$5K ﹤0.01%
683
-225
-25% -$2.01K
NVVE
4888
DELISTED
Nuvve Holding Corp
NVVE
0
IMDX
4889
Insight Molecular Diagnostics
IMDX
$141M
$5K ﹤0.01%
848
+173
+26% +$1.91K
ODC icon
4890
Oil-Dri
ODC
$1.31B
$5K ﹤0.01%
304
+126
+71% +$1.9K
OLB icon
4891
OLB
OLB
$4.37M
$5K ﹤0.01%
564
+232
+70% +$2.18K
ONEW icon
4892
OneWater Marine
ONEW
$198M
$5K ﹤0.01%
167
-955
-85% -$29.8K
OPAL icon
4893
OPAL Fuels
OPAL
$65.3M
$5K ﹤0.01%
665
-490
-42% -$3.95K
PDO
4894
PIMCO Dynamic Income Opportunities Fund
PDO
$1.82B
$5K ﹤0.01%
+409
New +$5.63K
PGX icon
4895
Invesco Preferred ETF
PGX
$3.77B
$5K ﹤0.01%
450
-87
-16% -$1.01K
PHAT icon
4896
Phathom Pharmaceuticals
PHAT
$775M
$5K ﹤0.01%
486
-3,965
-89% -$40.9K
PICK icon
4897
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.27B
$5K ﹤0.01%
111
+93
+517% +$3.64K
POLA icon
4898
Polar Power
POLA
$6.86M
$5K ﹤0.01%
511
+490
+2,333% +$7.02K
PUMP icon
4899
ProPetro Holding
PUMP
$1.49B
$5K ﹤0.01%
497
-8,996
-95% -$94.7K
RDCM icon
4900
Radcom
RDCM
$176M
$5K ﹤0.01%
+472
New +$4.9K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.